aTyr Pharma Inc (NASDAQ:LIFE)

2.40
Delayed Data
As of Apr 20
 -0.05 / -2.04%
Today’s Change
2.30
Today|||52-Week Range
6.50
-31.43%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +66.67% increase from the last price of 2.40.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.48
Sales
$0.00
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -22.10%
 
 
 
 
 
 
Growthannually 28.12%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.